{"meshTagsMajor":["Genes, erbB-2"],"meshTags":["Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Drug Resistance, Neoplasm","Female","Gene Amplification","Genes, erbB-2","Humans","Lung Neoplasms","Middle Aged","Mutation","Paclitaxel","Receptor, ErbB-2","Trastuzumab"],"meshMinor":["Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Combined Chemotherapy Protocols","Carcinoma, Non-Small-Cell Lung","Drug Resistance, Neoplasm","Female","Gene Amplification","Humans","Lung Neoplasms","Middle Aged","Mutation","Paclitaxel","Receptor, ErbB-2","Trastuzumab"],"genes":["HER2"],"publicationTypes":["Case Reports","Letter"],"title":"HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer.","pubmedId":"16775247"}